Clinical application of fluorescence in situ hybridization for chromosome 11q13 analysis in head and neck cancer

Laryngoscope

Volumn 109, Issue 6, 1999, Pages 874-879

  Alavi, Sassan ^a   Namazie, Ali ^a   Calcaterra, Thomas C ^b   Wang, Marilene B ^a   Srivatsan, Eri S ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b CHS 62 132 ^*

Author keywords

Chromosome 11q13; FISH; Head and neck tumors

Indexed keywords

PARAFFIN;

ADULT; AGED; ARTICLE; CANCER SURVIVAL; CHROMOSOME 11Q; CHROMOSOME ANALYSIS; CLINICAL ARTICLE; CONTROLLED STUDY; DIAGNOSTIC VALUE; DISEASE ASSOCIATION; DISEASE MARKER; DNA PROBE; FEMALE; FLUORESCENCE IN SITU HYBRIDIZATION; GENE AMPLIFICATION; GENE ISOLATION; GENE LOCATION; HEAD AND NECK CANCER; HUMAN; HUMAN CELL; HUMAN TISSUE; MALE; METASTASIS; PRIORITY JOURNAL; SURVIVAL RATE;

ADULT; AGED; AGED, 80 AND OVER; CARCINOMA, SQUAMOUS CELL; CASE-CONTROL STUDIES; CHROMOSOMES, HUMAN, PAIR 11; DIAGNOSIS, DIFFERENTIAL; FEMALE; HEAD AND NECK NEOPLASMS; HUMANS; IN SITU HYBRIDIZATION, FLUORESCENCE; MALE; MIDDLE AGED; NEOPLASM STAGING;

EID: 0032997422     PISSN: 0023852X     EISSN: None     Source Type: Journal    
DOI: 10.1097/00005537-199906000-00006     Document Type: Article

References (20)

1. Landis SH, Murray T, Bolden S, Wingo PA. Cancer Statistics 1998. CA Cancer J Clin 1998;41:19-36.
2. Stell P. Survival times in end-stage head and neck cancer. Eur J Surg Oncol 1989;5:407-410.
3. Michalides RJ, van Veelen NM, Kristel PM, Hart AA, Loftus BM, Hilgers FJ, Balm AJ. Overexpression of cyclin D1 indicates a poor prognosis in squamous cell carcinoma of the head and neck. Arch Otolaryngol Head Neck Surg 1997;123:497-502.
4. Serrano M, Hannon. GJ, Beach D. A new regulatory motif in cell cycle control causing specific inhibition of cyclin D/CDK4. Nature 1993;366:704-707.
5. Kamb A, Gruis NA, Weaver-Feldhaus J, Liu Q, Harshman K, Tavtigian SV, Stockert E, Day RS 3rd, Johnson BE, Skolnick MH. A cell cycle regulator potentially involved in genesis of many tumor types. Science 1994;264:436-440.
6. Lukas J, Pagano M, Staskova Z, Draetta G, Bartek J. Cyclin D1 protein oscillates and is essential for cell cycle progression in human tumor cell lines. Oncogene 1994;9:707-718.
7. Nobori T, Miura K, Wu DJ, Lois AF, Takabayashi K, Carson DA. Deletions of the cyclin-dependent kinase-4 inhibitor gene in multiple human cancers. Nature 1994;368: 753-756.
8. Ohta M, Inoue H, Cotticelli MG, Kastury K, Baffa R, Palazzo J, Siprashvili Z, Mori M, McCue P, Druck T, Croce CM, Huebner K. The human FHIT gene, spanning the chromosome 3p14.2 fragile site and renal carcinoma associated translocation breakpoint, is abnormal in digestive tract cancers. Cell 1996;84:587-597.
9. Maestro R, Piccinin S, Doglioni C, Gasparotto D, Vukosavljevic T, Salfaro S, Barzan L, Boiocchi M. Chromosome 13q deletion mapping in head and neck squamous cell carcinomas: Identification of two distinct regions of preferential loss. Cancer Res 1996;56:1146-1150.
10. Fearon ER, Cho KR, Nigro JM, Kern SE, Simons JW, Ruppert JM, Hamilton SR, Presinger AC, Thomas G, Kinzler KW, Vogelstein B. Identification of chromosome 18q gene that is altered in colorectal cancer. Science 1990;247: 49-56.
11. Devilee P, Thierry RF, Kievits T, Kolluri R, Hopman AH, Willard HF, Pearson PL, Cornelisse CJ. Detection of chromosome aneuploidy in interphase nuclei from human primary breast tumors using chromosome-specific repetitive DNA probes. Cancer Res 1988;48:5825-5830.
12. Hopman AH, Moesker O, Smeets AW, Pauwels PE, Vooijs GP, Ramaekers FC. Numerical chromosome 1, 7, 9, and 11 in bladder cancer detected by in situ hybridization. Cancer Res 1991;51:644-651.
13. Waldman FM, Carroll PR, Kerschmann R, Cohen MB, Field FG, Mayall BH. Centromeric copy number of chromosome 7 is strongly correlated with tumor grade and labeling index in human bladder cancer. Cancer Res 1991;51: 3807-3813.
14. Tsuji T, Mimura Y, Maeda K, Ida M, Sasaki K, Shinozaki F. Numerical aberrations of chromosome 17 detected by FISH with DNA-specific probe in oral tumors. Anticancer Res 1994;14:1689-1693.
15. Lammie GA, Fantl V, Smith R, Schuuring E, Brookes S, Michalides R, Dickson C, Arnold A, Peters G. D11S287, a putative oncogene on chromosome 11q13 is amplified and expressed in squamous cell and mammary carcinomas and linked to BCL-1. Oncogene 1991;6:439-444.
16. Williams ME, Gaffey MJ, Weiss LM, Wilcynski SP, Levine PA. Chromosome 11q13 amplification in head and neck squamous cell carcinoma. Arch Otolaryngol Head Neck Surg 1993;119:1238-1243.
17. Takes RP, Baatenburg de Jong RJ, Schuuring E, Hermans J, Vis AA, Litvinov SV, van Krieken JH. Markers of assessment of nodal metastasis in laryngeal carcinoma. Arch Otolaryngol Head Neck Surg 1997;123:412-419.
18. Pauletti G, Godolphin W, Press MF, Slamon DJ. Detection and quantitation of Her-2/neu gene amplification in human breast cancer archival material using fluorescence in situ hybridization. Oncogene 1996;13:63-72.
19. Voravud N, Shin DM, Ro JY, Lee J, Hong WK, Hittelman WN. Increased polysomies of chromosomes 7 and 17 during head and neck multistage tumorigenesis. Cancer Res 1993; 53:2874-2883.
20. Choi G, Chung K. Polysomies of chromosomes 7 and 17 in head and neck squamous cell carcinomas. Arch Otolaryngol Head Neck Surg 1996;122:1062-1067.